Benitec Biopharma Inc.

8-K Director or officer change May 29, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 10-K/A Fiscal year ended 2025-06-30 Mar 20, 2026 8-K Results of operations (earnings release) Feb 12, 2026 10-Q Quarter ended 2025-12-31 Feb 12, 2026 8-K Shareholder vote results Dec 2, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Entered a material agreement; Other events Nov 7, 2025 8-K Director or officer change; Regulation FD disclosure; Other events Nov 3, 2025 8-K Results of operations (earnings release) Sep 22, 2025 10-K Fiscal year ended 2025-06-30 Sep 22, 2025 8-K Previously issued financials not reliable Sep 12, 2025 8-K Regulation FD disclosure Jul 9, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Other events Mar 28, 2025 8-K Entered a material agreement Mar 27, 2025 8-K Entered a material agreement; Other events Mar 26, 2025 8-K Other events Mar 20, 2025 8-K Regulation FD disclosure Mar 19, 2025 8-K Results of operations (earnings release) Feb 14, 2025 10-Q Quarter ended 2024-12-31 Feb 14, 2025 8-K/A Director or officer change Dec 31, 2024 8-K Director or officer change Dec 13, 2024 8-K Modified rights of security holders; Amended charter or bylaws Dec 10, 2024 8-K Shareholder vote results Dec 6, 2024 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Director or officer change Nov 14, 2024 8-K Regulation FD disclosure Oct 15, 2024 8-K Entered a material agreement Oct 11, 2024 8-K Other events Oct 8, 2024 8-K Results of operations (earnings release) Sep 26, 2024 10-K Fiscal year ended 2024-06-30 Sep 26, 2024 8-K Director or officer change; Shareholder vote results Sep 5, 2024 8-K Regulation FD disclosure Jul 15, 2024 8-K Director or officer change Jul 1, 2024 8-K Results of operations (earnings release) May 13, 2024